Imago BioSciences (IMGO)
US Market

Imago BioSciences (IMGO) Financial Statements


Imago BioSciences Financial Overview

Imago BioSciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Imago BioSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -17.55M$ -14.02M$ -16.51M$ -14.81M$ -11.72M
EBITDA$ -17.55M$ -14.02M$ -16.51M$ -14.81M$ -11.72M
Net Income Common Stockholders$ -16.78M$ -13.74M$ -16.39M$ -14.73M$ -11.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 178.41M$ 190.01M$ 205.82M$ 217.41M$ 230.35M
Total Assets$ 186.46M$ 196.11M$ 212.45M$ 224.79M$ 237.28M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -178.41M$ -190.01M$ -205.82M$ -217.41M$ -230.35M
Total Liabilities$ 13.84M$ 8.77M$ 12.93M$ 10.09M$ 8.91M
Stockholders Equity$ 172.62M$ 187.34M$ 199.51M$ 214.69M$ 228.36M
Cash Flow-
Free Cash Flow$ -11.72M$ -15.77M$ -11.52M$ -13.29M$ -12.23M
Operating Cash Flow$ -11.72M$ -15.77M$ -11.52M$ -13.29M$ -12.22M
Investing Cash Flow$ -3.29M$ 30.26M$ 8.10M$ -61.08M$ -70.66M
Financing Cash Flow$ -475.00K$ 17.00K$ 454.00K$ 390.00K$ 161.50M
Currency in USD

Imago BioSciences Earnings and Revenue History

Imago BioSciences Debt to Assets

Imago BioSciences Cash Flow

Imago BioSciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis